Endometrial Cancer: Abnormal Bleeding, Biopsy, and Surgery

Endometrial cancer starts in the lining of the uterus and often causes abnormal bleeding, especially after menopause. Early evaluation with pelvic examination, ultrasound, and endometrial biopsy helps guide treatment, which commonly includes surgery.

Overview

Endometrial cancer is a cancer that begins in the endometrium, the inner lining of the uterus. The uterus is the organ where pregnancy develops, and the endometrium normally thickens and sheds during the menstrual cycle. Most endometrial cancers are diagnosed after symptoms appear, most often abnormal uterine bleeding.

This cancer is sometimes called uterine cancer, although other, less common cancers can also develop in the uterus. Endometrial cancer is generally separated into different types based on how the cancer cells look under a microscope and how they behave. Endometrioid adenocarcinoma is the most common type, while serous carcinoma, clear cell carcinoma, carcinosarcoma, and other high-grade types may need more intensive treatment.

Many people with endometrial cancer are diagnosed at an early stage because bleeding prompts medical evaluation. When found early, treatment can be very effective. Still, every patient is different, and care should be planned by a gynecologic oncology team that considers the tumor features, imaging results, surgical findings, and the person’s overall health.

Symptoms: Abnormal Bleeding and Other Warning Signs

The most important symptom of endometrial cancer is abnormal uterine bleeding. For someone who has gone through menopause, any vaginal bleeding, spotting, pink discharge, or brown discharge is considered abnormal and should be evaluated. It does not matter whether the bleeding is heavy or light, painful or painless, or whether it stops on its own.

Before menopause, warning signs can include bleeding between periods, very heavy periods, periods that last longer than usual, or bleeding after sexual intercourse. Because irregular bleeding can have many non-cancer causes, such as polyps, fibroids, hormonal changes, or infection, a medical assessment is needed to identify the reason.

Other possible symptoms may include pelvic discomfort, watery or blood-tinged vaginal discharge, pain during sexual intercourse, or unexplained fatigue if bleeding has caused anemia. Advanced disease can sometimes cause pelvic pain, abdominal swelling, changes in urination or bowel habits, or unintentional weight loss. These symptoms are not specific to cancer, but they are reasons to seek medical advice rather than waiting.

Causes and Risk Factors

Endometrial cancer develops when cells in the uterine lining acquire changes that allow them to grow in an uncontrolled way. In many cases, the risk is influenced by long-term exposure to estrogen without enough balancing progesterone. This hormonal pattern can cause the endometrium to thicken and, in some people, progress to precancerous changes or cancer.

Risk factors include increasing age, being after menopause, obesity, polycystic ovary syndrome, irregular or infrequent ovulation, early first period, late menopause, never having been pregnant, and certain estrogen-only hormone treatments after menopause. Diabetes and high blood pressure are also commonly associated with higher risk, partly because they often occur together with metabolic changes and excess body weight.

Some people have inherited risk. Lynch syndrome, a hereditary condition linked to changes in DNA repair genes, increases the risk of endometrial cancer as well as colorectal and several other cancers. A strong family history of endometrial, colorectal, ovarian, or related cancers should be discussed with a doctor, as genetic counseling may be recommended.

Tamoxifen, a medication used for some breast cancers, can slightly increase the risk of endometrial changes in postmenopausal patients. However, it also provides important benefits in breast cancer care. Anyone taking tamoxifen should not stop it without medical guidance, but should promptly report postmenopausal bleeding or unusual discharge.

Diagnosis: Pelvic Exam, Ultrasound, and Endometrial Biopsy

Diagnosis usually begins with a medical history and pelvic examination. The doctor asks about bleeding patterns, menopause status, medications, hormone treatments, pregnancies, medical conditions, and family history. A Pap test may be performed if cervical screening is due, but a Pap test is not designed to reliably detect endometrial cancer.

Transvaginal ultrasound is often used to measure the thickness of the endometrium and look for polyps, fibroids, ovarian findings, or other pelvic conditions. In postmenopausal bleeding, a thin endometrium on ultrasound can be reassuring in selected situations, but persistent or recurrent bleeding still needs further assessment. Ultrasound findings help guide the next step, but they do not replace tissue diagnosis when cancer is suspected.

An endometrial biopsy is one of the most important tests. During this office procedure, a thin instrument is passed through the cervix to collect a small sample of the uterine lining. Some cramping may occur, and the doctor may recommend simple comfort measures. The tissue is examined by a pathologist to identify cancer, atypical hyperplasia, or benign changes.

If an office biopsy is not possible, if the sample is insufficient, or if symptoms continue despite a benign result, hysteroscopy with dilation and curettage may be recommended. Hysteroscopy uses a small camera to view the inside of the uterus, allowing targeted sampling of suspicious areas such as polyps or focal thickening.

Staging and Treatment Planning

Once endometrial cancer is diagnosed, the care team determines the stage and risk category. Staging describes how far the cancer has spread, including whether it is limited to the uterus or involves the cervix, lymph nodes, ovaries, abdomen, or distant organs. In endometrial cancer, final staging is often confirmed after surgery, when the uterus and any sampled lymph nodes are examined.

Before surgery, imaging may be used depending on the biopsy results and symptoms. Pelvic MRI can help assess how deeply the cancer may involve the uterine muscle or cervix. CT, PET-CT, or chest imaging may be considered for higher-grade tumors or when spread outside the uterus is suspected. Blood tests are also used to assess general health before anesthesia and treatment.

Pathology provides essential information, including tumor type, grade, depth of invasion, lymphovascular space invasion, lymph node status, and sometimes molecular markers. Increasingly, molecular classification helps refine prognosis and treatment selection. These details allow doctors to decide whether surgery alone is sufficient or whether radiation, chemotherapy, hormone therapy, immunotherapy, or targeted treatment should be considered.

Treatment Options: Surgery and Additional Therapies

Surgery is the main treatment for many patients with endometrial cancer. The standard operation is usually a total hysterectomy, which removes the uterus and cervix, along with removal of both fallopian tubes and ovaries. Depending on the case, the surgeon may also perform sentinel lymph node mapping or lymph node removal to check whether cancer cells have spread.

Surgery may be performed through minimally invasive techniques, such as laparoscopy or robotic-assisted surgery, or through an open abdominal incision when medically necessary. The best approach depends on the size of the uterus, cancer features, previous surgeries, body habitus, and the surgeon’s assessment. Recovery plans include pain control, prevention of blood clots, gradual activity, wound care, and follow-up to review final pathology.

Additional treatment after surgery is called adjuvant therapy. Some patients need no further treatment, while others may benefit from vaginal brachytherapy, external beam radiation, chemotherapy, or a combination. Higher-grade cancers, lymph node involvement, deep muscle invasion, or certain aggressive tumor types may increase the need for additional therapy.

For selected patients who strongly wish to preserve fertility and have very early, low-grade disease limited to the endometrium, hormone-based treatment may be discussed with careful monitoring. This approach is not suitable for everyone and requires close follow-up with repeat sampling. For advanced or recurrent disease, treatment may include systemic chemotherapy, hormone therapy, immunotherapy, or targeted therapy based on tumor characteristics and overall health.

Prevention, Self-Care, and Follow-Up

Not all endometrial cancers can be prevented, but some risk factors can be modified. Maintaining a healthy weight, staying physically active, and managing diabetes or insulin resistance may help lower risk. People with irregular periods, polycystic ovary syndrome, or prolonged absence of periods should ask a doctor whether the endometrium needs protection with appropriate hormonal treatment.

Anyone using hormone therapy after menopause should review the risks and benefits with a healthcare professional. In general, people with a uterus who take systemic estrogen after menopause usually need a progestogen as well, unless there is a specific medical reason not to. Medication choices should always be individualized.

Follow-up after treatment is important. Visits usually focus on symptoms, pelvic examination when appropriate, recovery, management of side effects, and emotional well-being. Patients are encouraged to report new bleeding, pelvic pain, persistent cough, unexplained weight changes, leg swelling, or other concerning symptoms. Most follow-up does not require routine imaging unless symptoms or examination findings suggest a need.

Supportive care also matters. Fatigue, changes in sexual health, early menopause after ovary removal, urinary or bowel changes, and anxiety about recurrence are common topics that can be addressed. Nutrition guidance, pelvic floor therapy, menopause care, counseling, and survivorship support can improve quality of life during and after treatment.

When to See a Doctor

A doctor should be consulted for any bleeding after menopause, even a single episode of spotting. Premenopausal people should also seek evaluation for bleeding between periods, unusually heavy or prolonged bleeding, bleeding after sex, or new pelvic pain. Early assessment helps identify common benign causes and, when needed, allows timely diagnosis of precancerous or cancerous changes.

Urgent medical care is appropriate if bleeding is very heavy, causes dizziness or fainting, or is accompanied by severe pain, fever, or signs of infection. Patients already diagnosed with endometrial cancer should contact their care team if they develop new or worsening symptoms before or after treatment.

International patients may seek evaluation by gynecologic oncologists, pathologists, radiologists, and supportive care teams working together. Acibadem International provides multidisciplinary diagnosis and treatment for endometrial cancer in JCI-accredited hospitals, including care coordination for patients traveling from abroad.

Frequently asked questions

Is postmenopausal bleeding always endometrial cancer?

No. Postmenopausal bleeding can be caused by vaginal or endometrial thinning, polyps, fibroids, hormone therapy, infection, or other conditions. However, because endometrial cancer can also cause this symptom, any bleeding after menopause should be checked by a qualified doctor.

Does an endometrial biopsy hurt?

An endometrial biopsy can cause cramping that feels similar to menstrual cramps, and the discomfort is usually brief. Some people have light spotting afterward. The doctor can explain what to expect and which comfort measures are safe based on the patient’s medical history.

Can a Pap test detect endometrial cancer?

A Pap test is designed mainly to screen for cervical cancer, not endometrial cancer. Sometimes abnormal endometrial cells are seen on a Pap test, but a normal Pap test does not rule out endometrial cancer. Symptoms such as postmenopausal bleeding still require proper evaluation.

Will everyone with endometrial cancer need chemotherapy?

No. Many early-stage, lower-risk endometrial cancers are treated with surgery alone or surgery plus limited radiation. Chemotherapy is considered when the cancer has higher-risk features, has spread, or belongs to certain aggressive types. The decision is based on pathology, stage, molecular findings, and overall health.

Is hysterectomy always necessary?

Hysterectomy is the standard treatment for most patients because it removes the organ where the cancer started and allows accurate staging. In carefully selected patients with very early, low-grade disease who wish to preserve fertility, hormone-based treatment may be discussed. This option requires strict monitoring and is not appropriate for all cases.

What happens after surgery for endometrial cancer?

After surgery, the removed tissue is examined in detail by a pathologist. The care team then reviews the final stage and risk factors to decide whether any additional treatment is needed. Follow-up visits focus on recovery, symptom review, side effects, and long-term wellness.

References

• World Health Organization
• American Cancer Society
• National Cancer Institute
• European Society for Medical Oncology
• American College of Obstetricians and Gynecologists

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.